94 related articles for article (PubMed ID: 12183048)
1. Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice.
Kuo DY; Inui A; Cheng JT
Neurosci Lett; 2002 Sep; 329(3):359-61. PubMed ID: 12183048
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.
Kuo DY
Behav Brain Res; 2003 Dec; 147(1-2):149-55. PubMed ID: 14659580
[TBL] [Abstract][Full Text] [Related]
3. Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine.
Kuo DY; Hsu CT; Cheng JT
Life Sci; 2001 Dec; 70(3):243-51. PubMed ID: 12005258
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
[TBL] [Abstract][Full Text] [Related]
5. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY
J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced effects on neuropeptide Y in the rat brain.
Obuchowicz E; Turchan J; Przewłocki R; Herman ZS
Pharmacol Rep; 2005; 57(3):321-9. PubMed ID: 15985714
[TBL] [Abstract][Full Text] [Related]
7. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake.
Gillard ER; Dang DQ; Stanley BG
Brain Res; 1993 Nov; 628(1-2):128-36. PubMed ID: 8313139
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice.
Cannon CM; Abdallah L; Tecott LH; During MJ; Palmiter RD
Neuron; 2004 Oct; 44(3):509-20. PubMed ID: 15504330
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.
Kuo DY
Br J Pharmacol; 2006 Jul; 148(5):640-7. PubMed ID: 16702993
[TBL] [Abstract][Full Text] [Related]
10. NF-κB knockdown can modulate amphetamine-mediated feeding response.
Kuo DY; Chen PN; Kuo MH; Chen CH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Mar; 62(4):1684-94. PubMed ID: 22182781
[TBL] [Abstract][Full Text] [Related]
11. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
[TBL] [Abstract][Full Text] [Related]
12. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.
Hsieh YS; Chen PN; Yu CH; Chen CH; Tsai TT; Kuo DY
Neurotoxicology; 2015 May; 48():131-41. PubMed ID: 25825358
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system.
Obuchowicz E; Herman ZS
Pharmacol Rep; 2005; 57(6):850-5. PubMed ID: 16382207
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum.
Hsieh YS; Yang SF; Kuo DY
Regul Pept; 2005 Apr; 127(1-3):169-76. PubMed ID: 15680483
[TBL] [Abstract][Full Text] [Related]
15. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression.
Hsieh YS; Yang SF; Chiou HL; Kuo DY
Toxicol Appl Pharmacol; 2006 Apr; 212(2):99-109. PubMed ID: 16084549
[TBL] [Abstract][Full Text] [Related]
16. Participation of ghrelin signalling in the reciprocal regulation of hypothalamic NPY/POMC-mediated appetite control in amphetamine-treated rats.
Yu CH; Chu SC; Chen PN; Hsieh YS; Kuo DY
Appetite; 2017 Jun; 113():30-40. PubMed ID: 28229938
[TBL] [Abstract][Full Text] [Related]
17. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
Kuo DY
Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466
[TBL] [Abstract][Full Text] [Related]
18. Central dopamine action modulates neuropeptide-controlled appetite via the hypothalamic PI3K/NF-κB-dependent mechanism.
Hsieh YS; Chen PN; Yu CH; Kuo DY
Genes Brain Behav; 2014 Nov; 13(8):784-93. PubMed ID: 25160767
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.
Schwendt M; McGinty JF
Neuroscience; 2010 Jun; 168(1):96-107. PubMed ID: 20298760
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
Kuo DY
J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
